Variant constraint by mRNA vaccines

被引:2
|
作者
Bordon, Yvonne
机构
[1] Nature Reviews Immunology,
关键词
D O I
10.1038/s41577-021-00548-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants.
引用
收藏
页码:274 / 275
页数:2
相关论文
共 50 条
  • [31] A Comprehensive Review of mRNA Vaccines
    Gote, Vrinda
    Bolla, Pradeep Kumar
    Kommineni, Nagavendra
    Butreddy, Arun
    Nukala, Pavan Kumar
    Palakurthi, Sushesh Srivatsa
    Khan, Wahid
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [32] Analysis of mRNA Therapeutics and Vaccines
    Challener, Cynthia A.
    Pharmaceutical Technology, 2022, 46 (02) : 16 - 21
  • [33] Seeking new mRNA vaccines
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2022, 35 (02) : 9 - 9
  • [34] mRNA vaccines as cancer therapies
    Huang Shaoxiong
    Que Haiying
    Wang Manni
    Wei Xiawei
    中华医学杂志英文版, 2024, 137 (24)
  • [35] mRNA vaccines: A matter of delivery
    Cao, Yuhong
    Gao, George F.
    ECLINICALMEDICINE, 2021, 32
  • [36] The advances of adjuvants in mRNA vaccines
    Xie, Chunyuan
    Yao, Ruhui
    Xia, Xiaojun
    NPJ VACCINES, 2023, 8 (01)
  • [37] Recent innovations in mRNA vaccines
    Ulmer, Jeffrey B.
    Geall, Andrew J.
    CURRENT OPINION IN IMMUNOLOGY, 2016, 41 : 18 - 22
  • [38] THE TANGLED HISTORY OF MRNA VACCINES
    Dolgin, Elie
    NATURE, 2021, 597 (7876) : 318 - 324
  • [39] mRNA Vaccines to Combat Malaria
    Meena, Rajesh Kumar
    INDIAN PEDIATRICS, 2023, 60 (01) : 77 - 77
  • [40] The advances of adjuvants in mRNA vaccines
    Chunyuan Xie
    Ruhui Yao
    Xiaojun Xia
    npj Vaccines, 8